Skip to Content
Morningstar
Get 14 Days Free
Stock Analyst Update

Buying Opportunity in Pockets of Semiconductor Space

Multiple names are reaching or approaching 4-star territory.

Abhinav Davuluri
Mentioned: , ,
Editor’s note: Read the latest on how the coronavirus is rattling the markets and what investors can do to navigate it.

Semiconductor stocks have been hit hard in the wake of the novel coronavirus (COVID-19) epidemic that has severely disrupted both chip production and demand in China and neighboring countries. Shares of the PHLX semiconductor sector index are down 19% after peaking in mid-February. We had previously viewed many semiconductor names in our coverage universe as overvalued, but the recent pullback has led to multiple names reaching or approaching 4-star territory. Namely, Intel (INTC), Broadcom, Qualcomm, Xilinx, Applied Materials (AMAT), and KLA (KLAC) are all undervalued. Of these names, our top pick is wide-moat Intel ($70 per share fair value). Wide-moat equipment suppliers such as KLA and Applied also appear attractive at current levels, with unchanged fair value estimates of $160 and $65 per share, respectively.

We continue to expect competitive headwinds from AMD to impact Intel over the next few quarters. At its analyst day on March 5, AMD noted 15% of its 2019 sales came from the data center and set a long-term sales growth target of 20%, with data center contributing more than 30% of total revenue. We think this implies a $5 billion target for AMD’s data center sales (CPUs and GPUs) by 2024, which is considerably above our estimate of $3.5 billion (CPUs only). We believe Intel will ably navigate the near-term challenges while investing in critical process and design technologies (7-nanometer, Artificial Intelligence, and automotive).

Despite the uncertainty regarding COVID-19, Applied CEO Gary Dickerson noted he doesn’t anticipate a material impact to the firm’s 2020 results when the firm reported on Feb. 12. While revenue guidance for Applied’s next quarter would have been about $300 million higher at the midpoint absent the near-term risks, management was confident this shortfall was not permanent demand destruction. KLA’s management expects revenue in the March quarter to be $1.325 billion-$1.525 billion, with the coronavirus contributing to a wider-than-typical range.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Abhinav Davuluri does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.